🇺🇸 FDA
Pipeline program

Neoadjuvant Therapy

STARS-GC02

Phase 2 other active

Quick answer

Neoadjuvant Therapy for Gastric Cancer is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Gastric Cancer
Phase
Phase 2
Modality
other
Status
active

Clinical trials